Vantage Consulting Group Inc
- SEC CIK
- 0001843547
- Latest filing
- Feb 11, 2026
BIIB holding history
Biogen Inc. in every 13F filed by Vantage Consulting Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BIIB overviewAll 13F holders of BIIBFull Q4 2025 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −1,005−100.0% | Sold out | Holders |
| Q2 2024 | 1,005 | $233.0K | 0.2% | −60−5.6% | Reduced | Holders |
| Q1 2024 | 1,065 | $229.6K | 0.1% | +86+8.8% | Added | Holders |
| Q4 2023 | 979 | $253.3K | 0.2% | +80+8.9% | Added | Holders |
| Q3 2023 | 899 | $231.1K | 0.2% | +157+21.2% | Added | Holders |
| Q2 2023 | 742 | $211.4K | 0.1% | −193−20.6% | Reduced | Holders |
| Q1 2023 | 935 | $260.0K | 0.1% | +89+10.5% | Added | Holders |
| Q4 2022 | 846 | $234.3K | 0.1% | −362−30.0% | Reduced | Holders |
| Q3 2022 | 1,208 | $323.0K | 0.2% | −10−0.8% | Reduced | Holders |
| Q2 2022 | 1,218 | $248.0K | 0.1% | +58+5.0% | Added | Holders |
| Q1 2022 | 1,160 | $244.0K | 0.1% | +42+3.8% | Added | Holders |
| Q4 2021 | 1,118 | $268.0K | 0.1% | +305+37.5% | Added | Holders |
| Q3 2021 | 813 | $230.0K | <0.1% | +235+40.7% | Added | Holders |
| Q2 2021 | 578 | $200.0K | <0.1% | +578 | New | Holders |